MedPath

The comparission of EMLA cream and vapocoolant spray in reducing pain and anxity in catheterizatio

Not Applicable
Conditions
Pain during Venupuncture.
During aspiration, puncture and other catheterization
Registration Number
IRCT2015062222815N2
Lead Sponsor
niversity of Social Welfare and Rehabilitation Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria:
6-12 years old children with major thalassemia registered in thalassemia center; Full consciousness and fluency the Persian language to communicate appropriately and the ability to communicate verbally; Not using analgesics and anti anxiety agents

Exclusion Criteria

Any acute side effects related to the interventions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: In three phases: without intervention, after EMLA Cream and after Vapocoolant Spray application. Method of measurement: Visuale analoge Scale.
Secondary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: In three phases: without intervention, after EMLA Cream and after Vapocoolant Spray application. Method of measurement: Visuale analoge Scale for Anxiety.
© Copyright 2025. All Rights Reserved by MedPath